[
  {
    "ts": null,
    "headline": "Hartford Equity Income Fund Q4 2024 Commentary",
    "summary": "Hartford Equity Income Fund (I share) underperformed the Russell 1000 Value Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=f95c07e653005714d4816a7784c66ad729b2d2ab7264888ba8a672949ffd2bed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740435780,
      "headline": "Hartford Equity Income Fund Q4 2024 Commentary",
      "id": 132867316,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2095584352/image_2095584352.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Hartford Equity Income Fund (I share) underperformed the Russell 1000 Value Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=f95c07e653005714d4816a7784c66ad729b2d2ab7264888ba8a672949ffd2bed"
    }
  },
  {
    "ts": null,
    "headline": "Summit Therapeutics: Mid-2025 NSCLC Data Could Further Entrench Ivonescimab Program",
    "summary": "Summit Therapeutics: Mid-2025 NSCLC Data Could Further Entrench Ivonescimab Program",
    "url": "https://finnhub.io/api/news?id=e75694199b5d383eca67cf1725b2d2abe8cb0d8592b3c817410dbb07a2aaf7de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740411183,
      "headline": "Summit Therapeutics: Mid-2025 NSCLC Data Could Further Entrench Ivonescimab Program",
      "id": 132865578,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e75694199b5d383eca67cf1725b2d2abe8cb0d8592b3c817410dbb07a2aaf7de"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency",
    "summary": "Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency",
    "url": "https://finnhub.io/api/news?id=1bd4f5f8bd08de3bfa512d8c1495784973c8974a9e45da89c577c73c12083298",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740405840,
      "headline": "Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency",
      "id": 132881611,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency",
      "url": "https://finnhub.io/api/news?id=1bd4f5f8bd08de3bfa512d8c1495784973c8974a9e45da89c577c73c12083298"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: What The Summit Therapeutics Deal Brings",
    "summary": "Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab.",
    "url": "https://finnhub.io/api/news?id=833f1805a3f1d0b1c2a650a19c9f7e56846e0f2929f08cf0708520721c5eb678",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740394430,
      "headline": "Pfizer: What The Summit Therapeutics Deal Brings",
      "id": 132864260,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/912015932/image_912015932.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab.",
      "url": "https://finnhub.io/api/news?id=833f1805a3f1d0b1c2a650a19c9f7e56846e0f2929f08cf0708520721c5eb678"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Announces New Chief Medical Officer",
    "summary": "Monday, February 24, 2025 - 10:30am Share  New York, February 24, 2025 - Pfizer Inc. today announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer,...",
    "url": "https://finnhub.io/api/news?id=4171c1517914c1963aac586079d7e4feefc1a15cf94161abe723870d5fe54483",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740393306,
      "headline": "Pfizer : Announces New Chief Medical Officer",
      "id": 132864028,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Monday, February 24, 2025 - 10:30am Share  New York, February 24, 2025 - Pfizer Inc. today announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer,...",
      "url": "https://finnhub.io/api/news?id=4171c1517914c1963aac586079d7e4feefc1a15cf94161abe723870d5fe54483"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
    "summary": "Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45th Annual Health Care...",
    "url": "https://finnhub.io/api/news?id=13451c6d95c9e67090b7864704b843847c990838cfe7db85a03b150c74ec84f2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740391264,
      "headline": "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
      "id": 132863828,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45th Annual Health Care...",
      "url": "https://finnhub.io/api/news?id=13451c6d95c9e67090b7864704b843847c990838cfe7db85a03b150c74ec84f2"
    }
  },
  {
    "ts": null,
    "headline": "Don't Get Left Behind - The Great Rotation Into Dividend Stocks Is Here",
    "summary": "Dividend stocks are becoming safer bets for future returns, as highlighted by recent market analyses. Read more to see my thoughts.",
    "url": "https://finnhub.io/api/news?id=034a70d20ac9c5837dd0f6c30cea07df811a3bab178e868a2901df3a4c5fe6e5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740382200,
      "headline": "Don't Get Left Behind - The Great Rotation Into Dividend Stocks Is Here",
      "id": 132863010,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/173198842/image_173198842.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Dividend stocks are becoming safer bets for future returns, as highlighted by recent market analyses. Read more to see my thoughts.",
      "url": "https://finnhub.io/api/news?id=034a70d20ac9c5837dd0f6c30cea07df811a3bab178e868a2901df3a4c5fe6e5"
    }
  },
  {
    "ts": null,
    "headline": "Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos",
    "summary": "Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos",
    "url": "https://finnhub.io/api/news?id=6ba42582d3dfac86180eaba17e1af49c6baded69c2dee2a175574ae008817611",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740379440,
      "headline": "Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos",
      "id": 132883770,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos",
      "url": "https://finnhub.io/api/news?id=6ba42582d3dfac86180eaba17e1af49c6baded69c2dee2a175574ae008817611"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Balanced Income Fund Q4 2024 Commentary",
    "summary": "Hartford Balanced Income Fund (I Share) underperformed its benchmark. Global fixed-income markets generated negative total returns during the fourth quarter.",
    "url": "https://finnhub.io/api/news?id=8cf846021938805f1fdc3762989c1b2cfb2067476155afc8ecef7b18a85d910e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740378240,
      "headline": "Hartford Balanced Income Fund Q4 2024 Commentary",
      "id": 132862608,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2170553469/image_2170553469.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Hartford Balanced Income Fund (I Share) underperformed its benchmark. Global fixed-income markets generated negative total returns during the fourth quarter.",
      "url": "https://finnhub.io/api/news?id=8cf846021938805f1fdc3762989c1b2cfb2067476155afc8ecef7b18a85d910e"
    }
  },
  {
    "ts": null,
    "headline": "Afraid Of Investing In Individual Stocks? Consider This ETF Trifecta",
    "summary": "I have been recently adding ETFs as these are also great for building wealth. Check out the ETF trifecta you should consider for your portfolio and why.",
    "url": "https://finnhub.io/api/news?id=8b1a8771a01017d172c047f9bd8a971640b181cf823a942d644c382e2b4c99bd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740378180,
      "headline": "Afraid Of Investing In Individual Stocks? Consider This ETF Trifecta",
      "id": 132862618,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303055097/image_1303055097.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "I have been recently adding ETFs as these are also great for building wealth. Check out the ETF trifecta you should consider for your portfolio and why.",
      "url": "https://finnhub.io/api/news?id=8b1a8771a01017d172c047f9bd8a971640b181cf823a942d644c382e2b4c99bd"
    }
  }
]